# Mincle-dependent Th17 adjuvanticity requires TNFR1 signaling in myeloid cells

**Authors:** Robert Blamberg, Carl Haberkamp, Gabriel Kristian Pedersen, Ida Rosenkrands, Ulrike Schleicher, Barbara U. Schraml, Sho Yamasaki, Roland Lang

PMC · DOI: 10.3389/fimmu.2026.1746618 · Frontiers in Immunology · 2026-02-09

## TL;DR

This study shows that TNFR1 signaling in myeloid cells is essential for the Th17 adjuvanticity of the CAF01 vaccine adjuvant, which depends on Mincle upregulation.

## Contribution

The study identifies that TNFR1 signaling in myeloid cells, not dendritic or T cells, is critical for CAF01's Th17 adjuvanticity via Mincle upregulation.

## Key findings

- LysM-Cre-mediated deletion of TNFR1 in myeloid cells completely abrogated Th17 differentiation.
- Constitutive Mincle expression partially restored Th17 induction despite TNF blockade.
- Monocytes, not neutrophils, are essential for CAF01's adjuvant effect.

## Abstract

Successful induction of protective T cells by recombinant protein vaccines requires adjuvants. The liposomal adjuvant system CAF01 induces robust Th17 responses in mice. CAF01 contains the synthetic glycolipid trehalose-6,6-dibehenate (TDB), whose recognition by the C-type lectin receptor Mincle is required for Th17 induction. In previous work, we identified a pivotal role of TNF in upregulation of Mincle expression in macrophages and Th17 adjuvanticity of CAF01. The question has remained on which cell type(s) TNF acts to mediate the Th17 adjuvanticity of CAF01, and whether TNF-induced Mincle upregulation is causative. We used conditional TNFR1-deficient mice to dissect cell type-specific contributions of TNF signaling in myeloid cells, DC and T cells to Th17 induction by the recombinant tuberculosis fusion protein H1 adjuvanted with CAF01. LysM-Cre-mediated deletion of TNFR1 on myeloid cells completely abrogated vaccine-induced Th17 differentiation, replicating the phenotype in mice deficient in TNF or treated with the TNF blocker Etanercept. In contrast, TNFR1 deletion in DC by Clec9a-Cre did not affect Th17 induction, and by CD11c-Cre only partially reduced Th17 cells. T cell-specific deletion of TNFR1 by Lck-Cre had no impact on Th17 differentiation after vaccination. TNFR1 was expressed highly, and deleted efficiently via LysM-Cre, in monocytes and in neutrophils. We recently showed that neutrophils are not required for the adjuvant effect of CAF01, but monocytes are essential. Therefore, we analyzed activation of monocytes by TDB and observed robust upregulation of Mincle expression and of the Th17-inducing cytokines IL-1β and IL-6, that was inhibited by Etanercept. Finally, we asked whether Th17 induction by TNF is causally linked to Mincle upregulation. Constitutive, TNF-independent transgenic Mincle expression partially restored Th17 induction by CAF01 despite TNF blockade. Thus, upregulation of Mincle by TNF plays a causal role, likely by enabling production of Th17-polarizing cytokines by myeloid cells upon enhanced sensing of the adjuvant component TDB.

## Linked entities

- **Genes:** CLEC4E (C-type lectin domain family 4 member E) [NCBI Gene 26253], TNFRSF1A (TNF receptor superfamily member 1A) [NCBI Gene 7132], lysM (peptidoglycan-binding protein LysM) [NCBI Gene 1187091], CLEC9A (C-type lectin domain containing 9A) [NCBI Gene 283420], ITGAX (integrin subunit alpha X) [NCBI Gene 3687], LCK (LCK proto-oncogene, Src family tyrosine kinase) [NCBI Gene 3932]
- **Proteins:** TNF (tumor necrosis factor), IL1B (interleukin 1 beta), IL6 (interleukin 6)
- **Chemicals:** trehalose-6,6-dibehenate (PubChem CID 11170611)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** SAP130 (Sin3A associated protein 130) [NCBI Gene 79595], Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Lyz2 (lysozyme 2) [NCBI Gene 17105] {aka Lys, Lysm, Lyzf2, Lyzs, Lzm, Lzm-s1}, CD9 (CD9 molecule) [NCBI Gene 928] {aka BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29}, C5AR1 (complement C5a receptor 1) [NCBI Gene 728] {aka C5A, C5AR, C5R1, CD88}, Dpp4 (dipeptidylpeptidase 4) [NCBI Gene 13482] {aka Cd26, Dpp-4, THAM}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Cd44 (CD44 antigen) [NCBI Gene 12505] {aka HERMES, Ly-24, Pgp-1}, FCGR1A (Fc gamma receptor Ia) [NCBI Gene 2209] {aka CD64, CD64A, FCG1, FCGR1, FCRI, FcgammaRI}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Lck (lck proto-oncogene, Src family tyrosine kinase) [NCBI Gene 16818] {aka Hck-3, Lsk, Lskt, p56<lck>, p56Lck}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Ighg2b (immunoglobulin heavy constant gamma 2B) [NCBI Gene 16016] {aka IgG2b, Igh-3, gamma2b}, Il23a (interleukin 23, alpha subunit p19) [NCBI Gene 83430] {aka IL-23, p19}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, H2 (histocompatibility-2, MHC) [NCBI Gene 111364] {aka H-2, MHC-II}, Xcr1 (chemokine (C motif) receptor 1) [NCBI Gene 23832] {aka Ccxcr1, Gpr5, mXcr1}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, C5ar1 (complement component 5a receptor 1) [NCBI Gene 12273] {aka C5aR, C5r1, Cd88, D7Msu1}, Tlr9 (toll-like receptor 9) [NCBI Gene 81897], Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 12772] {aka Cc-ckr-2, Ccr2a, Ccr2b, Ckr2, Ckr2a, Ckr2b}, Ighg1 (immunoglobulin heavy constant gamma 1 (G1m marker)) [NCBI Gene 16017] {aka IgG1, Igh-4, VH7183}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, Mbl2 (mannose-binding lectin (protein C) 2) [NCBI Gene 17195] {aka L-MBP, MBL, MBL-C, MBP-C, RARF/P28A}, LCK (LCK proto-oncogene, Src family tyrosine kinase) [NCBI Gene 3932] {aka IMD22, LSK, YT16, p56lck, pp58lck}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Fcgr1 (Fc receptor, IgG, high affinity I) [NCBI Gene 14129] {aka CD64, FcgammaRI, IGGHAFC}, Itgax (integrin alpha X) [NCBI Gene 16411] {aka Cd11c, Cr4, N418}, DPP4 (dipeptidyl peptidase 4) [NCBI Gene 1803] {aka ADABP, ADCP2, CD26, DPPIV, TP103}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, Tnfrsf1b (tumor necrosis factor receptor superfamily, member 1b) [NCBI Gene 21938] {aka CD120b, TNF-R-II, TNF-R2, TNF-R75, TNF-alphaR2, TNFBR}, CLEC4E (C-type lectin domain family 4 member E) [NCBI Gene 26253] {aka CLECSF9, MINCLE}, Ighv1-9 (immunoglobulin heavy variable 1-9) [NCBI Gene 668478] {aka Gm16697, Igg2a}, ITGAX (integrin subunit alpha X) [NCBI Gene 3687] {aka CD11C, SLEB6}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, TNFRSF1B (TNF receptor superfamily member 1B) [NCBI Gene 7133] {aka CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Clec4e (C-type lectin domain family 4, member e) [NCBI Gene 56619] {aka Clecsf9, Mincle}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, SF3B3 (splicing factor 3b subunit 3) [NCBI Gene 23450] {aka RSE1, SAP130, SF3b130, STAF130}, Syk (spleen tyrosine kinase) [NCBI Gene 20963] {aka Sykb}, Ighg3 (Immunoglobulin heavy constant gamma 3) [NCBI Gene 380795] {aka IgG3}, TNFRSF1A (TNF receptor superfamily member 1A) [NCBI Gene 7132] {aka CD120a, FPF, TBP1, TNF-R, TNF-R-I, TNF-R55}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Il1 (interleukin 1 complex) [NCBI Gene 111343] {aka Il-1}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Card9 (caspase recruitment domain family, member 9) [NCBI Gene 332579] {aka Gm782}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, Fcer1g (Fc receptor, IgE, high affinity I, gamma polypeptide) [NCBI Gene 14127] {aka CD23, FcR-gamma, FcR[g], FcRgamma, Fce1g, FcepsilonRI}, Ly6c1 (lymphocyte antigen 6 family member C1) [NCBI Gene 17067] {aka Ly-6C, Ly-6C1, Ly6c}, Clec9a (C-type lectin domain family 9, member a) [NCBI Gene 232414] {aka 9830005G06Rik, DNGR-1}
- **Diseases:** influenza (MESH:D007251), inflammation (MESH:D007249), RA (MESH:D001172), hepatitis B (MESH:D006509), latent tuberculosis (MESH:D055985), Footpad swelling (MESH:D004487), infection (MESH:D007239), pneumonia (MESH:D011014), MTB infection (MESH:D014376), bleeding (MESH:D006470), IBD (MESH:D015212), narcosis (MESH:D053608), spondyloarthropathies (MESH:D025242), fungal and bacterial infections (MESH:D009181), dislocation (MESH:D004204)
- **Chemicals:** Aluminum (MESH:D000535), Cationic Adjuvant Formulation 01 (-), mineral oil (MESH:D008899), uric acid (MESH:D014527), ammonium chloride (MESH:D000643), Xylazin (MESH:D014991), Isoflurane (MESH:D007530), LPS (MESH:D008070), TDM (MESH:D003311), DDA (MESH:C015831), Adalimumab (MESH:D000068879), Glc-DAG (MESH:C014571), saponin (MESH:D012503), TDB (MESH:C507803), Infliximab (MESH:D000069285), PBS (MESH:D007854), glycolipid (MESH:D006017), isopropanol (MESH:D019840)
- **Species:** Mycobacterium tuberculosis variant bovis (biotype) [taxon 1765], Bacillus sp. CG (species) [taxon 1196795], Mycobacterium tuberculosis subsp. tuberculosis (subspecies) [taxon 182785], Klebsiella pneumoniae (species) [taxon 573], Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mus musculus (house mouse, species) [taxon 10090], Mycobacterium tuberculosis (species) [taxon 1773], Bordetella pertussis (species) [taxon 520], Chlamydia muridarum (agent of mouse pneumonitis, species) [taxon 83560]
- **Mutations:** S10A, S11A, R26R, S10C, S11D
- **Cell lines:** H1 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_HA53), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), C57BL/6N — Mus musculus (Mouse), Embryonic stem cell (CVCL_2H81), CAF01 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_A1PP)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926142/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926142/full.md

## References

89 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926142/full.md

---
Source: https://tomesphere.com/paper/PMC12926142